the aid library

LIST OPTIONS

Filter

5033

Children and the 2004 Indian Ocean Tsunami: UNICEF’s Response in Indonesia (2005-2008) - Child Protection

United Nations Children's Fund (UNICEF) (2009)

EVALUATION REPORT. This report is a synthesis of the evaluation of UNICEF's response to the 2004 Indian Ocean tsunami in Indonesia that was undertaken in August 2008 to July 2009. The evaluation assessed UNICEF's response in four sectors where it had major involvement: child protection; basic educat... more

Download (295)

View PDF (430)

Focus on the Right of Children with Disabilities to Live in the Community

European Coalition for Community Living (2006) C1

Download (433)

View PDF (506)

The impact of myopia and high myopia

World Health Organization (WHO) (2017) C_WHO

Report of the Joint World Health Organization–Brien Holden Vision Institute Global Scientific Meeting on Myopia | University of New South Wales, Sydney, Australia 16–18 March 2015

Download (316)

View PDF (702)

Guidance on Disability Inclusion for GBV Partners in Lebanon: Case Management of Survivors & At-risk Women, Children and Youth with Disabilities

Women's Refugee Commission (WRC) and UNICEF Lebanon (2018) CC

Persons with disabilities are one of the most vulnerable and socially excluded groups in any crisis-affected community. They may be in hidden in homes, overlooked during needs assessments and not consulted in the design of programs.4 While gender-based violence (GBV) affects women, girls, men and bo... more

External Link

TB financing in East Europe promotes unnecessary hospital admissions: the case of Armenia

Gillini, L.; K. Davtyan, H. Davtyan, et al. (2013) C2

The Journal of Infection in Developing Countries 7(3):289-292

Download (339)

View PDF (499)

Community Mental Health Practice. Seven essential Features for Scaling up in low- and middle-income Countries

Basic Needs Basic Rights (2009) CC

The seven essential features of practice for scaling up are described with great clarity. They are practical and universal, and encourage local innovation. They include policy, funding and local management structure, as well as working with all possible partners and developing local context adaptati... more

Download (202)

View PDF (225)

Toolkit for research and development of paediatric antiretroviral drugs and formulations

World Health Organization (WHO); Unitaid; Unicef; et al. World Health Organization (WHO); Unitaid; Unicef; et al. (2018) C_WHO

WHO and UNITAID in collaboration with IMPAACT (International Maternal Pediatric Adolescent AIDS Clinical Trials) network, PENTA (Paediatric European Network for Treatment of AIDS) foundation and experts from the Paediatric Antiretroviral Working Group

Download (192)

View PDF (240)

HIV/AIDS prevention and care among armed forces and UN peacekeepers: The Case of Eritrea

T. Nakari; D. Mathiot; G. Lescornec; et al. UNAIDS (Joint United Nations Programme on HIVAIDS); African Union; H6 Partnership; Unicef; UNDP; et al. (2003) C2

UNAIDS Series: Engaging uniformed services in the fight against AIDS - Case Study 1 Fighting AIDS

Download (164)

View PDF (193)

Status and methodology of publicly available national HIV care continua and 90-90-90 targets: A systematic review

R. Granich; S. Gupta; I. Hall; et al. Plos Medicine (2017) CC

Research Article PLOS Medicine | DOI:10.1371/journal.pmed.1002253 April 4, 2017

Download (151)

View PDF (229)

occupied Palestinian territory COVID-19 Response Plan (27 March 2020)

UN Office for the Coordination of Humanitarian Affairs (OCHA) (2020) C_WHO

The primary focus of the plan continues to be prevention, preparedness and treatment of the the Novel Coronavirus (COVID-19) outbreak. Central to the plan are the following overall objectives: To prevent further transmission of COVID-19 in the oPt; To provide adequate care for patients aff... more

Download (157)

View PDF (188)

What are relevant, feasible and effective approaches to promote acceptance, uptake and adherence to physical distancing measures for COVID-19 prevention and control?

Ryan, R.E.; et al. World Health Organization WHO, Regional Office of Europe (2021) C_WHO

Health Evidence Network synthesis report 72

Download (216)

View PDF (280)

National agrifood systems and COVID-19 in South Sudan: Effects, policy responses, and long-term implications

Food and Agriculture Organization of the United Nations FAO (2022) C1

The COVID-19 pandemic has put significant pressure on health systems all around the world. The drastic measures established to contain its spread are creating serious impediments to economic activity (including agrifood systems) and, consequently, to livelihoods and food security and nutrition.

Download (190)

View PDF (287)

Preventing disease through healthy environments: a global assessment of the burden of disease from environmental risks

Prüss-Ustün, A.; J. Wolf, C. Corvalán, et al. World Health Organization WHO (2018) C_WHO

The main message emerging from this new comprehensive global assessment is that premature death and disease can be prevented through healthier environments – and to a significant degree. Analysing the latest data on the environment-disease nexus and the devastating impact of environmental hazards ... more

Download (174)

View PDF (267)

Global Programme to Eliminate Lymphatic Filariasis

World Health Organization WHO (2013) C_WHO

The document explains why vector control is important in national programmes and describes the preparation of a tailor-made vector control plan for national programmes. It outlines entomological procedures for regular and specific vector control and how data should be analysed for better overall und... more

Download (185)

View PDF (236)

WHO's response to the Ukraine crisis

World Health Organisation (WHO) (2023) C_WHO

Since 24 February 2022, the war in Ukraine has caused widespread suffering to its people and serious damage to the country’s infrastructure. Attacks on the country’s health system and its power network threaten people, compromise the provision of health care, and complicate the distribution of ... more

Download (194)

View PDF (216)

Enquêtes par sites sentinelles sur la résistance acquise du VIH au dolutégravir chez les personnes sous traitement antirétroviral incluant ce médicament

World Health Organisation (WHO) (2023) C_WHO

Avec l’essor des traitements antirétroviraux (TAR) à base de dolutégravir (DTG) pour soigner les personnes vivant avec le VIH dans le monde, il est important d’estimer la vitesse à laquelle la résistance acquise au DTG apparaît dans les populations sous TAR. Bien que la résistance au DT... more

Download (124)

View PDF (134)

Mpox Testing Strategy - November 2024

Africa Center for Disease Control and Prevention (2024) CC

Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde...d in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries. In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response. As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa. more

Download (253)

View PDF (316)

Dual HIV/syphilis rapid diagnostic tests can be used as the first test in antenatal care

World Health Organization WHO (2019) C_WHO

Policy Brief. WHO recommends that pregnant women receive testing for HIV, syphilis and hepatitis B (HBSAg) at least once during pregnancy, preferably in the first trimester. Dual HIV/syphilis rapid diagnostic tests (RDTs) can be used as the first test for pregnant women as part of antenatal care (... more

Download (355)

View PDF (256)

WHO manual for HIV drug resistance testing using dried blood spot specimens

World Health Organization WHO (2020) C_WHO

HIV-1 drug resistance (HIVDR) genotyping is an essential component of the WHO global HIVDR surveillance strategy. Plasma “gold standard” specimen type for HIVDR genotyping, but its use may not be feasible in rural, remote areas in low- and middle-income countries, since preparing and storing it ... more

Download (333)

View PDF (444)

WHO country cooperation strategy 2014-2018, Myanmar

World Health Organization (WHO), Country Office for Myanmar (2014) C_WHO

The strategic priorities of the CCS 2014–2018 are:
(1) Strengthening the health system.
(2) Enhancing the achievement of communicable disease control targets.
(3) Controlling the growth of the noncommunicable disease burden.
(4) Promoting health throughout the life course.
... more